Learn about the Hysterosalpingo Foam Sonography (HyFoSy) Procedure at the 70th Annual Pacific Coast Reproductive Society (PCRS) Meeting, a forum focused on professional development in the field of reproductive medicine. This year the meeting returns to in-person participation at the Esmeralda Renaissance Resort from March 24 – 26, 2022. In alignment with PCRS’s mission of providing a valuable opportunity for the exchange of information and advancement of ideologies in reproductive medicine, it is our pleasure to announce the educational presentation, “Advances in Tubal Patency Testing” by Professor Mark Hans Emanuel, MD, PhD. The presentation will take place during the breakfast session on Friday, March 25th. Join professional colleagues in learning about the advantages of the HyFoSy procedure and view a live demo by ExEm® Foam Sonographer, Shannan Humphrey, RDMS. A brief Q&A will follow after completion of the presentation. Download flyer to learn more.
We welcome you to also visit our booth where you can meet one-on-one with team members to discuss the HyFoSy ultrasound tubal patency procedure. Team members will be discussing new offerings, reimbursement programs, and product ordering. Download Flyer to learn more.
About the Pacific Coast Reproductive Society (PCRS)
PCRS is a global, interactive organization that champions the field of reproductive medicine. PCRS believes in the core values of supportiveness, innovation, inclusiveness, collegiality, professional and personal development, and intimacy. The organization is a multidisciplinary medical specialty society providing Continuing Medical Education (CME) to physicians and allied healthcare professionals. PCRS offers the highest quality, innovative CME, designed and presented by thought leaders in reproductive medicine. It provides an outstanding forum for the exchange of information, and the advancement of the ideologies in reproductive medicine in a relaxed and collegial setting building relationships that foster the integration of current knowledge to ensure quality medical care for patients.
To learn more about PCRS and the PCRS 2022 Annual Meeting, visit: https://pcrs.memberclicks.net
About ExEm® Foam (air polymer-type A) intrauterine foam
ExEm® Foam ((air polymer-type A) intrauterine foam) is an innovative, FDA-approved product that offers a less invasive ultrasound procedure, a highly accurate alternative to other tubal patency assessment procedures, like laparoscopy or X-ray HSG. The contrast agent allows for easy recognition of tubal patency using the Foam procedure. During the tubal patency procedure, the foam is infused into the uterus by a healthcare professional to allow for visual assessment of fallopian tubes. If the tubes are patent the foam will appear as a thin, bright white line within the fallopian tubes and spill over the ovaries and into the peritoneal cavity when visualized with ultrasound. If the white line does not appear, the fallopian tubes might be occluded or blocked.
IMPORTANT SAFETY INFORMATION
ExEm® Foam should not be used on patients who are pregnant, have known or suspected lower genital tract inflammation or infection, have had a gynecologic procedure within the last 30 days, have vaginal bleeding, or have known or suspected reproductive tract neoplasia. Common side effects include pelvic and abdominal pain, vasovagal reactions (and associated symptoms such as nausea and faintness), and post-procedure spotting.
Click here for full prescribing information.
About ExEm® Foam Inc
ExEm® Foam Inc is focused on providing solutions to simplify infertility diagnosis and enhance the fertility journey. Drawing on its years of experience, the team develops innovative products that better meet the needs of today’s patient and healthcare professional. ExEm® Foam, the company’s first FDA-approved product, is indicated as a contrast drug for hysterosalpingo foam sonography, also known as HyFoSy, to assess whether there may be a blockage in the fallopian tubes in women with known or suspected infertility. ExEm® Foam has been used in more than 500,000 tubal patency procedures worldwide since it first launched in Europe in 2011. ExEm® Foam Inc is headquartered in Nashville, TN.
For more information, please visit www.exemfoam.com.
